共 50 条
- [6] Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration [J]. HIPERTENSION Y RIESGO VASCULAR, 2023, 40 (02): : 55 - 57
- [7] Cardiorenal Disease is the Most Common First CV Manifestation in Type 2 Diabetes [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104